Literature DB >> 31131389

Prevalence of atrial fibrillation in the Italian elderly population and projections from 2020 to 2060 for Italy and the European Union: the FAI Project.

Antonio Di Carlo1, Leonardo Bellino2, Domenico Consoli3, Fabio Mori4, Augusto Zaninelli5, Marzia Baldereschi1, Alessandro Cattarinussi6, Maria Grazia D'Alfonso4, Chiara Gradia3, Bruno Sgherzi7, Giovanni Pracucci6, Benedetta Piccardi1,6, Biancamaria Polizzi8, Domenico Inzitari1,6.   

Abstract

AIMS: To estimate prevalence of atrial fibrillation (AF) in a representative sample of the Italian elderly population, projecting figures for Italy and the European Union. METHODS AND
RESULTS: A cross-sectional examination of all subjects aged 65+ years from three general practices in Northern, Central, and Southern Italy started in 2016. Participants were administered a systematic and an opportunistic screening, followed by clinical and electrocardiogram confirmation. The study sample included 6016 subjects. Excluding 235 non-eligible, among the remaining 5781 participation was 78.3%, which left 4528 participants (mean age 74.5 ± 6.8 years, 47.2% men). Prevalence of AF was 7.3% [95% confidence intervals (CI) 6.6-8.1], higher in men and with advancing age (6.6% from systematic plus 0.7% from opportunistic screening). Using prevalence figures, Italian elderly having AF in 2016 were estimated at ∼1 081 000 (95% CI 786 000-1 482 000). Considering stable prevalence, this number will increase by 75% to ∼1 892 000 in 2060 (95% CI 1 378 000-2 579 000). European Union elderly having AF in 2016 were estimated at ∼7 617 000 (95% CI 5 530 000-10 460 000), increasing by 89% to ∼14 401 000 in 2060 (95% CI 10 489 000-19 647 000). In 2016, subjects aged 80+ years represented 53.5% of cases in Italy and 51.2% in the European Union; in 2060, 69.6% and 65.2%, respectively.
CONCLUSIONS: Our findings indicate a high burden of AF in coming decades, especially among the oldest-old, who carry the higher AF-related risk of stroke and medical complications. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author(s) 2019. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Atrial fibrillation; Epidemiology; European Union; Prevalence; Projections

Year:  2019        PMID: 31131389     DOI: 10.1093/europace/euz141

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  30 in total

Review 1.  Epidemiology of Atrial Fibrillation in the 21st Century: Novel Methods and New Insights.

Authors:  Jelena Kornej; Christin S Börschel; Emelia J Benjamin; Renate B Schnabel
Journal:  Circ Res       Date:  2020-06-18       Impact factor: 17.367

Review 2.  Safety and feasibility of same-day discharge following catheter ablation of atrial fibrillation: what is known and what needs to be explored?

Authors:  Sebastian König; Sergio Richter; Andreas Bollmann; Gerhard Hindricks
Journal:  Herz       Date:  2022-03-07       Impact factor: 1.443

Review 3.  Risk and Management of Bleeding Complications with Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Venous Thromboembolism: a Narrative Review.

Authors:  Stefano Ballestri; Elisa Romagnoli; Dimitriy Arioli; Valeria Coluccio; Alessandra Marrazzo; Afroditi Athanasiou; Maria Di Girolamo; Cinzia Cappi; Marco Marietta; Mariano Capitelli
Journal:  Adv Ther       Date:  2022-10-16       Impact factor: 4.070

4.  Identification of Health Expenditures Determinants: A Model to Manage the Economic Burden of Cardiovascular Disease.

Authors:  Fiorella Pia Salvatore; Alessia Spada; Francesca Fortunato; Demetris Vrontis; Mariantonietta Fiore
Journal:  Int J Environ Res Public Health       Date:  2021-04-27       Impact factor: 3.390

Review 5.  Genetics of atrial fibrillation-practical applications for clinical management: if not now, when and how?

Authors:  Shinwan Kany; Bruno Reissmann; Andreas Metzner; Paulus Kirchhof; Dawood Darbar; Renate B Schnabel
Journal:  Cardiovasc Res       Date:  2021-06-16       Impact factor: 10.787

6.  Challenges and opportunities in improving the management of atrial fibrillation: recent research advances and their clinical translation.

Authors:  Stanley Nattel; Gregory Y H Lip; David Filgueiras-Rama; Dobromir Dobrev
Journal:  Cardiovasc Res       Date:  2021-06-16       Impact factor: 13.081

Review 7.  Consensus Statement on Hemostatic Management, Anticoagulation, and Antiplatelet Therapy in Liver Transplantation.

Authors:  Eva Montalvá; Manuel Rodríguez-Perálvarez; Annabel Blasi; Santiago Bonanad; Olga Gavín; Loreto Hierro; Laura Lladó; Elba Llop; Juan Carlos Pozo-Laderas; Jordi Colmenero
Journal:  Transplantation       Date:  2022-01-04       Impact factor: 5.385

8.  A multicenter prospective cohort study to investigate the effectiveness and safety of apixaban in Japanese elderly atrial fibrillation patients (J-ELD AF Registry).

Authors:  Ken Okumura; Takeshi Yamashita; Shinya Suzuki; Masaharu Akao
Journal:  Clin Cardiol       Date:  2019-11-18       Impact factor: 2.882

9.  Inflammatory and lipid regulation by cholinergic activity in epicardial stromal cells from patients who underwent open-heart surgery.

Authors:  Marinela Couselo-Seijas; José N Lopez-Canoa; Ángel L Fernandez; Laila González-Melchor; Luisa M Seoane; Darío Duran-Muñoz; Adriana Rozados-Luis; José Ramón González-Juanatey; Moisés Rodríguez-Mañero; Sonia Eiras
Journal:  J Cell Mol Med       Date:  2020-08-07       Impact factor: 5.310

Review 10.  Psychological aspects of atrial fibrillation: A systematic narrative review : Impact on incidence, cognition, prognosis, and symptom perception.

Authors:  Karl-Heinz Ladwig; Andreas Goette; Seryan Atasoy; Hamimatunnisa Johar
Journal:  Curr Cardiol Rep       Date:  2020-09-10       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.